Clinical trial of medication that targets triglycerides

Published:

USC Clinical Trials will participate in a study of an investigational medication for the treatment of dyslipidaemia – a condition that involves abnormally elevated levels of lipids (fats) in the blood.

The injectable medication aims to reduce specific forms of lipids, known as triglycerides, but could also reduce total cholesterol and bad cholesterol (known as LDL cholesterol).

High triglycerides are associated with increased risk of clogged arteries, heart attacks, strokes and circulatory issues and disorders, and often cause no symptoms. They are also often present in diabetes patients, making them more susceptible to vascular and circulatory complications.

USC Clinical Trials Operations Manager Georgina Street said this trial could help broaden the range of treatment options available for patients with dyslipidaemia.

“We will investigate a potential new therapy that could reduce triglycerides and therefore reduce the incidence of heart attacks, strokes and associated vascular or circulatory disorders in the community,” she said.   

“Participants will be required to attend 11 clinic visits over a period of 25 weeks and receive two injections of the investigational medication one month apart.”

Mrs Street said the trial would be conducted alongside general practitioner Dr Susan Thackwray at the USC Clinical Trials Centre in Sippy Downs.

Dr Thackwray said there were currently limited treatments available for people with dyslipidaemia.  

“Treatments that target high cholesterol can reduce your bad cholesterol by 30-50 percent, but usually only decrease your triglycerides by 10-20 percent,” she said. “And we know that high triglycerides are as important to treat as high cholesterol, and that there is a large unmet need for lowering lipids.”

She said patients with known or suspected high triglycerides, diabetic patients, patients with a known or suspected family history of high triglycerides, and patients already on lipid-lowering drugs could be eligible to participate in this trial.

“They will be able to continue their usual diabetic and lipid-lowering medications during the study period,” she said.

Adults aged 18-65 are encouraged to consider participating. Those who meet the criteria and are enrolled in the study will be reimbursed for their time. Patients interested in participating can go to usc.edu.au/trials.

 
Community Health & Wellness Science & Research Surveys & Your Say University & TAFE
Social:   

University Of The Sunshine Coast : View Full Profile
90 Sippy Downs Drive, Sippy Downs
07 5430 1234
University Of The Sunshine Coast
Showing 10+ recent articles for this business
USC researchers gain grants: Managing AI risks and reducing methane from cows 06 December 2019 | Research projects at USC to tackle two major global threats – climate change and unchecked artificial intelligence – have been boosted by nearly $1million in Australian Research Council Discovery Project... More information...
USC research to diagnose ‘invisible’ illness faster 09 December 2019 | A USC researcher has been awarded a prestigious National Health and Medical Research Council grant worth more than $1.2million to help find the underlying neurobiological factors that cause chronic fatigue synd... More information...
Hollywood star praises USC koala detection dog 04 December 2019 | A USC detection dog called Bear that is working to find injured and displaced koalas after recent bushfires in Australia has gained the attention of Hollywood heavyweights Tom Hanks and Leonardo DiCaprio. More information...
Graduate wins prestigious young planner award 04 December 2019 | A USC planning graduate described as a brilliant role model to others across Australia has been named Queensland’s Young Planner of the Year. More information...
USC academic launches ‘Christmas book’ with a twist 04 December 2019 | A best-selling new novel written last Christmas on the Sunshine Coast may play on popular Christmas song lyrics – but the story is far from whimsical. More information...
Job hunt support for students with a disability 02 December 2019 | USC has signed up for a national employment support program aimed at improving job opportunities for university graduates with a disability. More information...
Students’ water use device wins three national awards 01 December 2019 | An innovative device created by four USC Engineering Honours students to give householders more control over their water use has won three national GovHack awards. More information...
Doctoral playwright shines light on stay-at-home dads 02 December 2019 | Former theatre director and drama educator Richard Finn has drawn from his latest role in life to write a play for his Doctor of Creative Arts at USC. More information...
Sustainable business focus for Orange Sky leader 29 November 2019 | An organisation that provides regular laundry and shower services for people experiencing homelessness has appointed a USC graduate to lead its operations around Australia and New Zealand.  More information...
Clinical trial of medication that targets triglycerides 01 December 2019 | USC Clinical Trials will participate in a study of an investigational medication for the treatment of dyslipidaemia – a condition that involves abnormally elevated levels of lipids (fats) in the blood. More information...


comments powered by Disqus

All articles submitted by third parties or written by My Sunshine Coast come under our Disclaimer / Terms of Service